NABsys Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NABsys Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10868
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NABsys Inc (NABsys) is a biomedical service provider. The company designs and develops semiconductor-based tools for genomic analysis. It develops semiconductor based nanodetectors to analyze DNA molecules electronically. NABsys provides platform to detect the positions of hybridized DNA probes and develops algorithms to reconstruct the DNA sequence. The company’s technology has applications in clinical diagnostics, drug development and basic research. Its technology uses solid-state nanodetectors to analyze single DNA molecules. The company offers semiconductor-based nanodetectors to enable direct electrical detection of tagged DNA. It develops products for cancer genomics, genome research and AgBio applications. NABsys is headquartered in Providence, Rhode Island, the US.

NABsys Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NABsys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NABsys Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NABsys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NABsys Inc, Medical Devices Deals, 2012 to YTD 2018 8
NABsys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
NABsys Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Nabsys Raises USD25.5 Million in Venture Financing 10
Nabsys Raises US$20 Million In Series D Financing Round 11
Nabsys Raises US$35 million In Venture Financing 12
Equity Offering 13
Nabsys to Raise USD42 Million in Financing 13
NABsys Inc – Key Competitors 14
NABsys Inc – Key Employees 15
NABsys Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
NABsys Inc, Pharmaceuticals & Healthcare, Key Facts 2
NABsys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
NABsys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NABsys Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NABsys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NABsys Inc, Medical Devices Deals, 2012 to YTD 2018 8
NABsys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nabsys Raises USD25.5 Million in Venture Financing 10
Nabsys Raises US$20 Million In Series D Financing Round 11
Nabsys Raises US$35 million In Venture Financing 12
Nabsys to Raise USD42 Million in Financing 13
NABsys Inc, Key Competitors 14
NABsys Inc, Key Employees 15

List of Figures
NABsys Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NABsys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NABsys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NABsys Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NABsys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NABsys Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[NABsys Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medicines for Malaria Venture(製薬・医療分野):企業M&A動向
    Summary Medicines for Malaria Venture (MMV) is a pharmaceutical and healthcare service provider. The company discovers, develops and delivers antimalarial drugs. It develops products that provide efficacy against drug-resistant strains of Plasmodium falciparum, potential for intermittent treatments, …
  • Teva Pharmaceutical Industries Ltd (TEVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, …
  • Midatech Pharma US Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Midatech Pharma US Inc. (Midatech Pharma) formerly know as Dara BioSciences, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of cancer treatment and supportive care products. The company’s product portfolio includes Soltamox, for the treatment …
  • Wanbury Limited (WANBURY):企業概要、財務及び戦略的SWOT分析
    Summary Wanbury Limited (Wanbury) is a pharmaceuticals and healthcare company. The company manufactures and sells Active Pharmaceutical Ingredient (API). It also offers contract research, contract manufacturing and software consulting and infrastructure solutions. The company focuses on the therapeu …
  • Parametric Technology Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Parametric Technology Corporati …
  • Honeywell Aerospace(航空宇宙・防衛):企業概要及びSWOT分析
    Summary Strategic Defence Intelligence's "Honeywell Aerospace: Aerospace and Defense - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, busin …
  • Ranbaxy Laboratories Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ranbaxy Laboratories Limited Me …
  • Amcor Limited:企業のM&A・提携・投資分析
    Amcor Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amcor Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Ezion Holdings Limitedの企業概要及び財務/SWOT分析
    Ezion Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterl …
  • The J.M. Smucker Co:企業の戦略・SWOT・財務情報
    The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report Summary The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sorrento Therapeutics Inc (SRNE):企業財務及び戦略的SWOT分析
    Summary Sorrento Therapeutics Inc (STI), formerly QuikByte Software, Inc., which develops novel treatments for cancer, inflammation and autoimmune diseases. It discovers small molecules, antibody drug conjugates, and antibodies for the treatment of cancer and its associated pain. Its pipeline produc …
  • Far East Consortium International Ltd:企業の戦略・SWOT・財務情報
    Far East Consortium International Ltd - Strategy, SWOT and Corporate Finance Report Summary Far East Consortium International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Mendes Junior Trading E Engenharia S.A. (MEND5):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Mendes Junior Trading E Engenharia S.A." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Tim …
  • Airbus S.A.S – Manufacturing Plant – Augsburg, Germany:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Airbus S.A.S - Manufacturing Pl …
  • Bruker Daltonics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bruker Daltonics, Inc. Mergers …
  • Pengrowth Energy Corporation (PGF):企業の財務及び戦略的SWOT分析
    Summary Pengrowth Energy Corporation (Pengrowth) is an energy company that acquires, explores, develops and produces oil and natural gas reserves. The company’s projects include Greater Olds or Garrington light oil and Swan Hills light oil, among others. It also manages diversified collection of ass …
  • Workday, Inc.:企業のM&A・提携・投資分析
    Workday, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Workday, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Mattel, Inc.:企業概要・SWOT・財務分析
    Summary Canadean's "Mattel, Inc. : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description …
  • Advanced Systems Automation Limited (5TY):企業の財務及び戦略的SWOT分析
    Summary Advanced Systems Automation Limited (ASAL) a subsidiary of ASTI Holdings Limited is a manufacturing company that manufactures automated backend equipment for semiconductors. The company offers products and services through categories such as align and attach, encapsulation, singulation and s …
  • NextPharma Technologies Holding Ltd:企業のM&A・提携動向(医療分野)
    Summary NextPharma Technologies Holding Ltd (NextPharma) is a pharmaceutical contract development and manufacturing organization that offers various pharmaceutical dosage forms such as solid, liquid and Semi-solids. The organization offers services such as pharmaceutical development, clinical trials …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆